Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127037900> ?p ?o ?g. }
- W2127037900 endingPage "1617" @default.
- W2127037900 startingPage "1611" @default.
- W2127037900 abstract "Low-grade ovarian serous carcinomas are believed to arise via an adenoma-serous borderline tumor-serous carcinoma sequence. In this study, we found that advanced-stage, low-grade ovarian serous carcinomas both with and without adjacent serous borderline tumor shared similar regions of loss of heterozygosity. We then analyzed 91 ovarian tumor samples for mutations in TP53, BRAF, and KRAS. TP53 mutations were not detected in any serous borderline tumors (n = 30) or low-grade serous carcinomas (n = 43) but were found in 73% of high-grade serous carcinomas (n = 18). BRAF (n = 9) or KRAS (n = 5) mutation was detected in 47% of serous borderline tumors, but among the low-grade serous carcinomas (39 stage III, 2 stage II, and 2 stage I), only one (2%) had a BRAF mutation and eight (19%) had a KRAS mutation. The low frequency of BRAF mutations in advanced-stage, low-grade serous carcinomas, which contrasts with previous findings, suggests that aggressive, low-grade serous carcinomas are more likely derived from serous borderline tumors without BRAF mutation. In addition, advanced-stage, low-grade carcinoma patients with BRAF or KRAS mutation have a better apparent clinical outcome. However, further investigation is needed." @default.
- W2127037900 created "2016-06-24" @default.
- W2127037900 creator A5014312007 @default.
- W2127037900 creator A5018745283 @default.
- W2127037900 creator A5019407817 @default.
- W2127037900 creator A5042887409 @default.
- W2127037900 creator A5070496227 @default.
- W2127037900 creator A5078692182 @default.
- W2127037900 creator A5081617588 @default.
- W2127037900 creator A5085045114 @default.
- W2127037900 creator A5088938634 @default.
- W2127037900 creator A5091121024 @default.
- W2127037900 date "2010-10-01" @default.
- W2127037900 modified "2023-10-17" @default.
- W2127037900 title "BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas" @default.
- W2127037900 cites W1966010019 @default.
- W2127037900 cites W1967450348 @default.
- W2127037900 cites W1974120530 @default.
- W2127037900 cites W1980267304 @default.
- W2127037900 cites W1992508898 @default.
- W2127037900 cites W2002191689 @default.
- W2127037900 cites W2003448468 @default.
- W2127037900 cites W2009978569 @default.
- W2127037900 cites W2012683206 @default.
- W2127037900 cites W2013892055 @default.
- W2127037900 cites W2017408894 @default.
- W2127037900 cites W2019544036 @default.
- W2127037900 cites W2019983709 @default.
- W2127037900 cites W2024386612 @default.
- W2127037900 cites W2026842096 @default.
- W2127037900 cites W2044464259 @default.
- W2127037900 cites W2049544369 @default.
- W2127037900 cites W2053263835 @default.
- W2127037900 cites W2055344345 @default.
- W2127037900 cites W2057058351 @default.
- W2127037900 cites W2061451800 @default.
- W2127037900 cites W2063309655 @default.
- W2127037900 cites W2071605994 @default.
- W2127037900 cites W2086725870 @default.
- W2127037900 cites W2094345248 @default.
- W2127037900 cites W2108731032 @default.
- W2127037900 cites W2110227850 @default.
- W2127037900 cites W2114852376 @default.
- W2127037900 cites W2115596977 @default.
- W2127037900 cites W2122410503 @default.
- W2127037900 cites W2122634638 @default.
- W2127037900 cites W2125255775 @default.
- W2127037900 cites W2128745883 @default.
- W2127037900 cites W2138021465 @default.
- W2127037900 cites W2145474139 @default.
- W2127037900 cites W2161080185 @default.
- W2127037900 cites W2163820705 @default.
- W2127037900 cites W2164533868 @default.
- W2127037900 cites W2322804680 @default.
- W2127037900 cites W4212835986 @default.
- W2127037900 doi "https://doi.org/10.2353/ajpath.2010.100212" @default.
- W2127037900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2947258" @default.
- W2127037900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20802181" @default.
- W2127037900 hasPublicationYear "2010" @default.
- W2127037900 type Work @default.
- W2127037900 sameAs 2127037900 @default.
- W2127037900 citedByCount "174" @default.
- W2127037900 countsByYear W21270379002012 @default.
- W2127037900 countsByYear W21270379002013 @default.
- W2127037900 countsByYear W21270379002014 @default.
- W2127037900 countsByYear W21270379002015 @default.
- W2127037900 countsByYear W21270379002016 @default.
- W2127037900 countsByYear W21270379002017 @default.
- W2127037900 countsByYear W21270379002018 @default.
- W2127037900 countsByYear W21270379002019 @default.
- W2127037900 countsByYear W21270379002020 @default.
- W2127037900 countsByYear W21270379002021 @default.
- W2127037900 countsByYear W21270379002022 @default.
- W2127037900 countsByYear W21270379002023 @default.
- W2127037900 crossrefType "journal-article" @default.
- W2127037900 hasAuthorship W2127037900A5014312007 @default.
- W2127037900 hasAuthorship W2127037900A5018745283 @default.
- W2127037900 hasAuthorship W2127037900A5019407817 @default.
- W2127037900 hasAuthorship W2127037900A5042887409 @default.
- W2127037900 hasAuthorship W2127037900A5070496227 @default.
- W2127037900 hasAuthorship W2127037900A5078692182 @default.
- W2127037900 hasAuthorship W2127037900A5081617588 @default.
- W2127037900 hasAuthorship W2127037900A5085045114 @default.
- W2127037900 hasAuthorship W2127037900A5088938634 @default.
- W2127037900 hasAuthorship W2127037900A5091121024 @default.
- W2127037900 hasBestOaLocation W21270379001 @default.
- W2127037900 hasConcept C104317684 @default.
- W2127037900 hasConcept C121608353 @default.
- W2127037900 hasConcept C126322002 @default.
- W2127037900 hasConcept C142724271 @default.
- W2127037900 hasConcept C143998085 @default.
- W2127037900 hasConcept C146357865 @default.
- W2127037900 hasConcept C150173356 @default.
- W2127037900 hasConcept C151730666 @default.
- W2127037900 hasConcept C2777632260 @default.
- W2127037900 hasConcept C2780427987 @default.
- W2127037900 hasConcept C2780964533 @default.
- W2127037900 hasConcept C2781182431 @default.